We are live on ! Find out more
NVNO icon

enVVeno Medical

5 hedge funds and large institutions have $298K invested in enVVeno Medical in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

939% more capital inflows, than outflows

Capital inflows: $322K | Capital outflows: $31K

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

67% more funds holding

Funds holding: 3 → 5 (+2)

1.24% more ownership

Funds ownership: 0.55% → 1.79% (+1.2%)

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

NVNO Hedge Fund Activity: Q4 2018 in Review

5 of the 4,507 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q4 2018, worth a combined $298K — up 72% from $173K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NVNO positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $187K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $29K sold.

  • 5 institutional investors held enVVeno Medical (NVNO) as of Q4 2018, up from 3 in Q3 2018.
  • Funds reported $298K of enVVeno Medical stock for Q4 2018, up 72% quarter-over-quarter.
  • 4 funds opened new enVVeno Medical positions in Q4 2018 and 2 closed out, a net change of +2 holders.
  • The largest enVVeno Medical buyer in Q4 2018 was Vanguard Group, an estimated $187K added.
  • The largest enVVeno Medical seller in Q4 2018 was Susquehanna International Group, an estimated $29K sold.

Based on aggregated 13F filings for Q4 2018.